Home › Eczema › Washington
Eczema clinical trials in Washington, DC
4 studies for Eczema are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Washington D.C.
Effects of Treatments on Atopic Dermatitis
RecruitingPhase 2Healthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Cardamom and Topical Roseomonas in Atopic Dermatitis
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
About Eczema
Eczema is a general term for different types of rashes. Atopic dermatitis, the most common type, is an allergic skin reaction. Read about treatments.
More about Eczema on MedlinePlus
Eczema trials in other cities
- San Antonio, TX7 studies
- Birmingham, AL6 studies
- New York City, NY5 studies
- Los Angeles, CA5 studies
- San Diego, CA5 studies
- Indianapolis, IN5 studies
- Miami, FL4 studies
- Huntington Beach, CA4 studies
- Santa Clarita, CA4 studies
- Phoenix, AZ4 studies
- Pittsburgh, PA4 studies
- San Francisco, CA3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.